AgomAb Therapeutics NV

AGMB

$11.94

▲ +0.8% Today

as of Jun 24, 09:15 ET

Last 30 days +13.18% May 15 → Jun 23

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$583M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 3 items

Jun 23 · 21:32 MT Newswires

Agomab Therapeutics Shares NOV-ERA Phase 2b Study Design With Ontunisertib in Fibrostenosing Crohn's Disease

Jun 23 · 20:05 PR GlobeNewswire

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease

May 14 · 11:30 PR GlobeNewswire

Agomab to Participate in Upcoming Conferences

Overview

52-week range

—

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Upcoming

Date	Fiscal	Time	EPS Est	LY EPS	YoY %Δ
Thu Jul 23, 2026	Mar/2026	OTHER	-$0.43	—

Implied volatility — last 90 days

No IV snapshots yet for AGMB.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗